Synthesis and in vitro and in vivo characterization of highly β1-Selective β-Adrenoceptor partial agonists
β-Adrenoceptor antagonists boast a 50-year use for symptomatic control in numerous cardiovascular diseases. One might expect highly selective antagonists are available for the human β-adrenoceptor subtype involved in these diseases, yet few truly β1-selective molecules exist. To address this clinica...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
American Chemical Society
2013
|
| Online Access: | https://eprints.nottingham.ac.uk/30316/ |